Updating!
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Sangoma Technologies Corp
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
40-F | Document | Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4 Acc-no: 0001753368-24-000014 (34 Act) Size: KB |
Sep-18-2024 | 241308223 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001753368-24-000013 (34 Act) Size: KB |
Sep-18-2024 | 241308208 |
SD | Document | Acc-no: 0001104659-24-064123 (34 Act) Size: KB | May-22-2024 | 24972387 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001753368-24-000008 (34 Act) Size: KB |
May-08-2024 | 24927330 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001753368-24-000004 (34 Act) Size: KB |
Feb-08-2024 | 24610099 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000945621-24-000171 (34 Act) Size: KB |
Feb-05-2024 | 24595591 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001172661-24-000430 (34 Act) Size: KB |
Feb-02-2024 | 24590179 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001753368-23-000031 (34 Act) Size: KB |
Dec-13-2023 | 231482507 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001753368-23-000029 (34 Act) Size: KB |
Nov-16-2023 | 231412207 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001753368-23-000027 (34 Act) Size: KB |
Nov-08-2023 | 231389080 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001753368-23-000023 (34 Act) Size: KB |
Oct-13-2023 | 231324855 |
S-8 | Document | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001104659-23-105047 (33 Act) Size: KB |
Sep-29-2023 | 231291965 |
40-F/A | Document | Amendment to Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4 Acc-no: 0001104659-23-104883 (34 Act) Size: KB |
Sep-29-2023 | 231291501 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001753368-23-000021 (34 Act) Size: KB |
Sep-27-2023 | 231285387 |
40-F | Document | Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4 Acc-no: 0001753368-23-000020 (34 Act) Size: KB |
Sep-27-2023 | 231285379 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001104659-23-086373 (34 Act) Size: KB |
Aug-01-2023 | 231131901 |
SC 13D | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001193125-23-175247 (34 Act) Size: KB |
Jun-26-2023 | 231043228 |
SD | Document | Acc-no: 0001104659-23-064171 (34 Act) Size: KB | May-24-2023 | 23954854 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001753368-23-000008 (34 Act) Size: KB |
May-11-2023 | 23911703 |
SC 13D | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001193125-23-140885 (34 Act) Size: KB |
May-10-2023 | 23907769 |
Recent 20 filings. View all Sangoma Technologies Corp filings
Very good communication and delivery made within the timeframe I was advised of
Huge help thank you for your help .. y'all make it so much easier
Thanks I look forward to using the product to improve my skin tone
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by